Specialty Pharmacy

Study identifies a potential association between azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma.

The FDA is taking new steps to better ensure the quality of compounded drugs, while also preserving patient access to these medications.

Study shows a novel treatment approach that could prevent gene changes associated with the disease.

Top news of the day from across the health care landscape.

Treatment with tezepelumab reduced annual asthma exacerbation rates in patients with severe asthma without an eosinophilic phenotype.

Treatment with ibudilast reduced the progression of brain atrophy in patients with progressive multiple sclerosis compared with a placebo.

Officials with the FDA have approved a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film for the maintenance treatment of opioid dependence.

Top news of the day from across the health care landscape.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses the potential for specialty pharmacies to become the norm.

The new formulation is the only immune globulin available in the United States that is approved for post-exposure protection against hepatitis A and measles.

Ozanimod reduced the number of brain lesions and lowered relapse rates in patients with relapsing multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.

The approval of riluzole oral suspension fills a therapeutic need for patients with amyotrophic lateral sclerosis who develop swallowing impairment.

Hub services act to simplify the complexity and perform as an intermediary between involved parties.

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection.

Through their Medicaid and Ryan White HIV/AIDS Programs, states play an integral role in ensuring access to care for people living with HIV.

Study provides insight into how cannabidiol acts in the brain to reduce psychotic symptoms.

Top news of the day from across the health care landscape.

New report assesses the quality of rheumatic disease care across all 50 states and calls for improvements that address access to affordable care.

FDA has granted priority review designation for Merck’s request for a supplemental biologics license application for pembrolizumab to treat Merkel cell carcinoma, a rare skin cancer.

Patients with multiple sclerosis who smoked cigarettes had higher rates of respiratory complications and increased sedentary lifestyle.

Top news of the day from across the health care landscape.

Some older women undergoing chemotherapy for breast cancer may be more susceptible to declining physical function and inability to recover function.

Combined ipilimumab and nivolumab treatment produced durable responses in patients with melanoma brain metastases.

Supplementing a commonly used treatment approach with an additional inhibitor could help overcome resistance in glioblastoma.

Gordon Vanscoy, PharmD, MBA, explains the challenges patients face when being treated with orphan drugs, and how pharmacists can help overcome these challenges.

Top news of the day from across the health care landscape.